11 Results for "

Curcumin analog

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "Curcumin analog" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-126154
CAS No.: 343307-76-6
Purity:  97.13%
Research Areas:  

Inflammation/Immunology

L48H37 is an analog of Curcumin (HY-N0005) with improved chemical stability. L48H37 is a potent and specific myeloid differentiation protein 2 (MD2) inhibitor and inhibits the interaction and signaling transduction of LPS-TLR4/MD2. L48H37 is used for the research of sepsis or lung injury treatment .
loading...
    loading...
Cat. No.: HY-W009731
CAS No.: 120-46-7
Dibenzoylmethane, a minor ingredient in licorice, activates Nrf2 and prevents various cancers and oxidative damage. Dibenzoylmethane, an analog of curcumin, results in dissociation from Keap1 and nuclear translocation of Nrf2 .
loading...
    loading...
Cat. No.: HY-148598
CAS No.: 890984-26-6
Purity:  98.58%
Synonyms: CUR5-8
Target:  

Apoptosis Autophagy

Research Areas:  

Metabolic Disease

Curcumin 5-8 (CUR5-8) is a potent and orally active naturally active curcumin (CUR) analog. Curcumin 5-8 inhibits lipid droplet formation. Curcumin 5-8 increases autophagy and inhibits Apoptosis. Curcumin 5-8 improves insulin resistance and insulin sensitivity .
loading...
    loading...
Cat. No.: HY-136477
CAS No.: 27060-70-4
Purity:  99.84%
Synonyms: PGV-1
Target:  

Apoptosis COX VEGFR NF-κB

Research Areas:  

Cancer

Pentagamavunon-1 (PGV-1), a Curcumin analog with oral activity, targets on several molecular mechanisms to induce apoptosis including inhibition of angiogenic factors cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF). PGV-1 inhibits NF-κB activation .
loading...
    loading...
Cat. No.: HY-139211
CAS No.: 1170354-22-9
Synonyms: 3,4-Difluorobenzylidene Curcumin
Research Areas:  

Cancer

Difluorinated Curcumin (3,4-Difluorobenzylidene curcumin) is a fluorinated curcumin analog with high bioavailability and anticancer activity. Difluorinated Curcumin inhibits the self-renewal ability of tumor stem/stem-like cells, clonogenicity, invasiveness and angiogenesis of tumor cells. Difluorinated Curcumin also increases cell sensitivity to chemotherapy .
loading...
    loading...
Cat. No.: HY-179398
Target:  

Keap1-Nrf2

Research Areas:  

Cancer

Keap1-Nrf2-IN-29 (Compound 1a), a Curcumin (HY-N0005) analog, is a Keap1 protein inhibitor. Keap1-Nrf2-IN-29 exhibits significant inhibitory activity against A549, PC-3 and MCF-7 cells. Keap1-Nrf2-IN-29 can be used for the study of prostate cancer .
loading...
    loading...
Cat. No.: HY-163458
Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Anti-inflammatory agent 77 (C12) is a β-cycloacinamide derived mono-carbonyl curcumin analog and an inhibitor of interleukin-6 (IL-6). Anti-inflammatory agent 77 can be used in the study of wound healing .
loading...
    loading...
Cat. No.: HY-W009731R
CAS No.: 120-46-7
Dibenzoylmethane (Standard) is the analytical standard of Dibenzoylmethane. This product is intended for research and analytical applications. Dibenzoylmethane, a minor ingredient in licorice, activates Nrf2 and prevents various cancers and oxidative damage. Dibenzoylmethane, an analog of curcumin, results in dissociation from Keap1 and nuclear translocation of Nrf2 .
loading...
    loading...
Cat. No.: HY-186288
CAS No.: 3061366-78-4
Research Areas:  

Cancer

DYRK2 ligand 2 is a curcumin analog and an inhibitor targeting DYRK2, which serves as a ligand for target protein for PROTAC against DYRK2. DYRK2 ligand 2 is applicable to studies related to PROTAC synthesis, such as for PROTAC DYRK2 degrader-2 (HY-186287) .
loading...
    loading...
Cat. No.: HY-186287
CAS No.: 3061366-74-0
Target:  

PROTACs DYRK

Research Areas:  

Cancer

PROTAC DYRK2 degrader-2 is a PROTAC DYRK2 degrader based on curcumin analog A3. It recruits the CRBN E3 ligase to mediate DYRK2 ubiquitination and achieves degradation via the ubiquitin-proteasome system. PROTAC DYRK2 degrader-2 downregulates the expression level of DYRK2 protein in cancer cells. It is applicable to cancer-related research .
loading...
    loading...
Cat. No.: HY-183402
CAS No.: 917813-60-6
Synonyms: GO-Y026
Research Areas:  

Cancer

FLLL12 (GO-Y026) is a curcumin analog anticancer agent. FLLL12 inhibits the phosphorylation of AKT, Bcl-2, Bid, EGFR, mTOR, FOXO1a, FOXO3a, STAT3, HER2/neu, as well as pancreatic AKT/STAT3; upregulates the expression of Bim and DR5; and activates PTPs. FLLL12 regulates downstream pathways, induces mitochondria-mediated and DR5-dependent extrinsic apoptosis, inhibits cancer cell viability, proliferation, anchorage-independent growth and migration, and exerts a synergistic effect with Doxorubicin (HY-15142A). FLLL12 can be used in research related to head and neck squamous cell carcinoma, breast cancer, prostate cancer, pancreatic cancer, lung cancer, colon cancer and colorectal cancer .
loading...
    loading...
  • 1